Groprim – proven viral protection

In Ukraine, the number of patients with coronavirus disease (COVID-19) is constantly increasing. This leads to an additional request for antiviral drugs in the country.

The pharmaceutical company Astrapharm produces the antiviral drug Groprim – an important tool to treat and prevent the spread of viruses during a pandemic. The active ingredient of Groprim is inosine pranobex. The drug inhibits the synthesis of a wide range of viruses, such as:

• viral respiratory infections;
• viral infections caused by herpes simplex virus types 1 and 2, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus, measles virus, mumps virus, including patients with immunodeficiency states;
• papillomavirus infections of the skin and mucous membranes: genital warts, papillomavirus infection of the vulva, vagina and cervix (as part of complex treatment);
• acute viral encephalitis (as part of complex treatment);
• viral hepatitis (as part of complex treatment);
• subacute sclerosing panencephalitis (as part of complex treatment).

Groprim also has an immunomodulatory effect: the drug normalizes (to the individual norm) cellular immunity.

Groprim comes in tablets, that contain 500 mg of inosine pranobex №20 and №40.

The drug is dispensed on prescription only.

Astrapharm – the art of helping people!